Sales of Lilly’s top-selling product, the diabetes treatment Mounjaro, jumped 60% to $3.53 billion in the final quarter of ...
Investing.com - Eli Lilly’s (NYSE: LLY) full-year profit forecast largely surpassed Wall Street expectations on Thursday, as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback